Mineralys Therapeutics, Inc. (MLYS)

NASDAQ: MLYS · Real-Time Price · USD

22.88

-0.77 (-3.26%)

At close: Mar 24, 2026, 4:00 PM EDT

22.70

-0.18 (-0.79%)

Pre-market: Mar 25, 2026, 5:12 AM EDT

Mineralys Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	172.92	114.09	49.3	87.7	10.61
Short-Term Investments	483.71	84.1	187.26	22.41	-
Cash & Short-Term Investments	656.64	198.19	236.57	110.11	10.61
Cash Growth	231.32%	-16.22%	114.85%	937.60%	653.16%
Other Current Assets	4.75	7.16	12.54	2.7	0.51
Total Current Assets	661.39	205.35	249.1	112.81	11.12
Net Property, Plant & Equipment	0.04	0.05	-	-	-
Long-Term Investments	-	-	2.48	-	-
Other Long-Term Assets	0.38	0.5	0.05	1.63	0
Total Assets	661.81	205.9	251.64	114.44	11.13
Accounts Payable	2.02	0.48	0.6	1.91	0.76
Accrued Expenses	13.1	14.17	9.88	6.16	4.29
Total Current Liabilities	15.11	14.65	10.48	8.07	5.05
Total Liabilities	15.11	14.65	10.48	8.07	5.05
Common Stock	0.01	0.01	0	0	0
Additional Paid-in Capital	1,104	493.77	365.86	0.54	0.09
Retained Earnings	-457.17	-302.52	-124.71	-52.81	-23.01
Total Common Shareholders' Equity	646.69	191.26	241.15	-52.27	-22.93
Minority Interest	-	-	-	158.64	29
Shareholders' Equity	646.69	191.26	241.15	106.38	6.07
Total Liabilities & Equity	661.81	205.9	251.64	114.44	11.13
Net Cash (Debt)	656.64	198.19	236.57	110.11	10.61
Net Cash Growth	231.32%	-16.22%	114.85%	937.60%	-
Net Cash Per Share	9.71	4.08	6.54	21.31	2.13
Book Value	646.69	191.26	241.15	-52.27	-22.93
Book Value Per Share	9.56	3.94	6.66	-10.12	-4.60
Tangible Book Value	646.69	191.26	241.15	-52.27	-22.93
Tangible Book Value Per Share	9.56	3.94	6.66	-10.12	-4.60

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q